Table 26: Bioheart, Inc. - Ongoing Clinical Trials Overview
Table 27: MyoCath - A Phase I, Open-Label, Non-Randomized, Dose Escalation, Multi Center Study to Assess the Safety and Cardiovascular Effects of Autologous Skeletal Myoblast Implantation by a Transendocardial Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s) With Previous Placement of ICD
Table 28: MyoCath - A Phase II, Open-Label, Randomized, Multicenter Study To Assess The Safety And Cardiovascular Effects Of MyoCell Implantation By A Catheter Delivery System In Congestive Heart Failure Patients Post Myocardial Infarction
Table 51: NOGA Guided Myostar Injection Catheter - A Phase I, Open-label Study of the Effects of Percutaneous Administration of an Extracellular Matrix Hydrogel, VentriGel, Following Myocardial Infarction
Table 71: ENABLER-C Catheter System - The ENABLER 3C Study Is Investigating The Safety And Efficacy Of The ENABLER-C Catheter System In Facilitating Guidewire Advancement Through Chronic Total Occlusions In The Coronary Arteries
Table 147: Topspin Medical Inc. - Ongoing Clinical Trials Overview
Table 148: IntraVascular MRI catheter - Prospective Data Collection in Clinical Cases Where Coronary Plaque Lipid Characterization by IVMRI Was Performed During Diagnostic or Interventional Catheterization Procedures
GlobalData's Medical Devices sector report, “Cardiac Catheters - Pipeline Review, 2015 provides an overview of Cardiac Catheters currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Catheters pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Extensive coverage of the Cardiac Catheters under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Cardiac Catheters and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Cardiac Catheters under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date